Stay updated on Bedaquiline and Delamanid Combo in DR-TB Clinical Trial
Sign up to get notified when there's something new on the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page.

Latest updates to the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has undergone significant content changes, including the removal of detailed study information regarding the safety and pharmacokinetics of anti-tuberculosis drugs, and the addition of a new registry identifier and revision number.SummaryDifference28%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has added helpful links related to the National Institute of Allergy and Infectious Diseases, specifically regarding grading adverse events and expedited reporting. There was a deletion of a notice about heavy traffic affecting some services.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
Stay in the know with updates to Bedaquiline and Delamanid Combo in DR-TB Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bedaquiline and Delamanid Combo in DR-TB Clinical Trial page.